These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19351919)

  • 1. Provider treatment intensity and outcomes for patients with early-stage bladder cancer.
    Hollenbeck BK; Ye Z; Dunn RL; Montie JE; Birkmeyer JD
    J Natl Cancer Inst; 2009 Apr; 101(8):571-80. PubMed ID: 19351919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.
    Huo J; Ray-Zack MD; Shan Y; Chamie K; Boorjian SA; Kerr P; Jana B; Freedland SJ; Kamat AM; Mehta HB; Williams SB
    Eur Urol Oncol; 2019 Sep; 2(5):497-504. PubMed ID: 31411998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of care for early stage bladder cancer.
    Strope SA; Ye Z; Hollingsworth JM; Hollenbeck BK
    Cancer; 2010 Jun; 116(11):2604-11. PubMed ID: 20310051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the variation in treatment intensity among patients with early stage bladder cancer.
    Hollingsworth JM; Zhang Y; Krein SL; Ye Z; Hollenbeck BK
    Cancer; 2010 Aug; 116(15):3587-94. PubMed ID: 20564128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying better practices for early-stage bladder cancer.
    Hollingsworth JM; Zhang YS; Miller DC; Skolarus TA; Wood DP; Lee CT; Montie JE; Hollenbeck BK
    Med Care; 2011 Dec; 49(12):1112-7. PubMed ID: 21979371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in early stage bladder cancer care and outcomes.
    Skolarus TA; Ye Z; Zhang S; Hollenbeck BK
    Urology; 2010 Aug; 76(2):391-6. PubMed ID: 20394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of radical cystectomy for patients with invasive bladder cancer.
    Gore JL; Litwin MS; Lai J; Yano EM; Madison R; Setodji C; Adams JL; Saigal CS;
    J Natl Cancer Inst; 2010 Jun; 102(11):802-11. PubMed ID: 20400716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does treatment intensity matter in superficial bladder cancer? Consensus, clinical practice, and confounding.
    Lyman GH; Kuderer NM; Freedland SJ
    J Natl Cancer Inst; 2009 Apr; 101(8):543-5. PubMed ID: 19351926
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project.
    Huang GJ; Hamilton AS; Lo M; Stein JP; Penson DF
    J Urol; 2008 Aug; 180(2):520-4; discussion 524. PubMed ID: 18550088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Rates and Health Care Costs for Patients With Advanced Bladder Cancer Treated and Untreated With Chemotherapy.
    Flannery K; Cao X; He J; Zhong Y; Shah AY; Kamat AM
    Clin Genitourin Cancer; 2018 Aug; 16(4):e909-e917. PubMed ID: 29735397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer.
    Hershman DL; Buono DL; Malin J; McBride R; Tsai WY; Neugut AI
    J Natl Cancer Inst; 2009 Dec; 101(23):1633-41. PubMed ID: 19903808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of bladder tumors.
    Madeb R; Golijanin D; Noyes K; Fisher S; Stephenson JJ; Long SR; Knopf J; Lyman GH; Messing EM
    Cancer; 2009 Jun; 115(12):2660-70. PubMed ID: 19455607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Patterns and Outcomes in Stage IV Bladder Cancer in a Community Oncology Setting: 2008-2015.
    Fisher MD; Shenolikar R; Miller PJ; Fenton M; Walker MS
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1171-e1179. PubMed ID: 30206026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding bladder cancer death: tumor biology versus physician practice.
    Morris DS; Weizer AZ; Ye Z; Dunn RL; Montie JE; Hollenbeck BK
    Cancer; 2009 Mar; 115(5):1011-20. PubMed ID: 19152434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment Patterns and Overall Survival Outcomes of Octogenarians with Muscle Invasive Cancer of the Bladder: An Analysis of the National Cancer Database.
    Fischer-Valuck BW; Rao YJ; Rudra S; Przybysz D; Germino E; Samson P; Baumann BC; Gay H; Michalski J
    J Urol; 2018 Feb; 199(2):416-423. PubMed ID: 28842247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to surveillance among patients with superficial bladder cancer.
    Schrag D; Hsieh LJ; Rabbani F; Bach PB; Herr H; Begg CB
    J Natl Cancer Inst; 2003 Apr; 95(8):588-97. PubMed ID: 12697851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cost to Medicare of Bladder Cancer Care.
    Sloan FA; Yashkin AP; Akushevich I; Inman BA
    Eur Urol Oncol; 2020 Aug; 3(4):515-522. PubMed ID: 31412015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder Cancer.
    Novotny V; Froehner M; Ollig J; Koch R; Zastrow S; Wirth MP
    Urol Int; 2016; 96(2):136-41. PubMed ID: 26789626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.